Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Harga saat ini dari 1HOLX.MI adalah €63.5 EUR — turun sebesar -1.55% dalam 24 jam terakhir. Pantau kinerja harga saham Hologic lebih dekat di grafik.
Apa simbol saham Hologic?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Hologic diperdagangkan dengan simbol 1HOLX.MI.
Berapa kapitalisasi pasar Hologic?▼
Hari ini Hologic memiliki kapitalisasi pasar sebesar 14.15B
Kapan tanggal laporan keuangan berikutnya dari Hologic?▼
Hologic akan merilis laporan keuangan berikutnya pada April 30, 2026.
Bagaimana laporan keuangan Hologic pada kuartal lalu?▼
Laporan keuangan 1HOLX.MI untuk kuartal terakhir adalah 0.87 EUR per saham, sedangkan perkiraannya 0.92 EUR, menghasilkan kejutan sebesar -5.08%. Perkiraan laba untuk kuartal berikutnya adalah N/A EUR per saham.
Berapa pendapatan Hologic tahun lalu?▼
Pendapatan Hologic tahun lalu berjumlah 7.18B EUR.
Berapa pendapatan bersih Hologic tahun lalu?▼
Pendapatan bersih 1HOLX.MI untuk tahun lalu adalah 985.93M EUR.
Berapa jumlah karyawan Hologic?▼
Per Februari 02, 2026, perusahaan memiliki 6,944 karyawan.
Hologic berada di sektor apa?▼
Hologic beroperasi di sektor Healthcare.
Kapan Hologic menyelesaikan split saham?▼
Hologic belum melakukan split saham baru-baru ini.
Di mana kantor pusat Hologic?▼
Kantor pusat Hologic berlokasi di Marlborough, United States.